ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Restoration of Walking in Multiple Sclerosis Using Treadmill Training.

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00156676
  Purpose

The primary purpose of this study is to collect preliminary and pilot data to begin to determine whether the use of body weight support treadmill therapy (BWSTT) with and without driven-gait-orthotics (DGO), results in improved motor recovery and ambulation MS patients with gait impairment


Condition Intervention
Multiple Sclerosis
Device: Body-weight supported treadmill
Device: Lokomat

MedlinePlus related topics:   Multiple Sclerosis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study
Official Title:   Pilot Study on Gait & Motor Function in MS Using BWS Treadmill Training

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Mean changes and variances in ambulation, motor, fatigue and quality of life [ Time Frame: Baseline, cross-over, study endpoint ] [ Designated as safety issue: No ]

Estimated Enrollment:   30
Study Start Date:   September 2004
Study Completion Date:   September 2007
Primary Completion Date:   September 2007 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1 Device: Body-weight supported treadmill Device: Lokomat

Detailed Description:

Gait impairment is a major cause of ongoing disability in patients with multiple sclerosis (MS). New treadmills that provide body weight support and even robotic assistance to the lower limbs have recently been developed and are now commercially available. These treadmills allow the subject to execute the integrated process of walking in a task-specific manner that is repetitively reinforced in a normal pattern. Data from studies using these body-weight supported treadmills (BWSTT) in spinal cord injury and stroke patients suggest that intensive task-specific gait rehabilitative training may help to restore a normative gait pattern, improve overground walking and enhance quality of life in multiple sclerosis patients with neurological gait impairment. In this study, we propose a series of prospective longitudinal clinical studies to collect pilot data on the use of task-specific BWSTT +/- Lokomat on improving ambulation, motor function and quality of life for MS patients with mild to moderate gait difficulty. Pilot data will also be collected for the effect conventional rehabilitation has on ambulation and motor outcomes as well as how these outcomes change during usual care. Our clinical research goals are to capture the initial pilot data (mean changes and variances in ambulation, motor, fatigue and quality of life outcomes) to facilitate the design of a larger clinical trial to test efficacy if these preliminary data are promising. The planned studies will study the effect of two forms of task specific training (BWSTT alone and BWSTT combined with Lokomat) compared to conventional gait rehabilitative methods and usual care

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

Clinical diagnosis of MS by McDonald criteria. EDSS level between 4-6.5.

Exclusion Criteria:

  1. Cardiovascular: recent MI < 4 wk, uncontrolled HTN >190/110 mmHg, Uncontrolled diabetes (blood glucose 2X above the upper limit of normal or non-fasting blood drain).
  2. Symptomatic fall in blood pressure (>30mm Hg), when upright in the body support apparatus, despite medical therapy.c)Circulatory problems, history of vascular claudication or pitting edema.

d)Cognitive impairment MMSE < 21.e)Body weight over 150 kg (structural limits of the Lokomat). f)Lower extremity injuries that limit range of motion or function. g)Joint problems (hip or leg) that limit range of motion or cause pain with movement despite treatment. h)Unstable fractures. i)Pressure sores with any skin breakdown in areas in contact with the body harness or DGO apparatus. j)Chronic and ongoing alcohol or drug abuse. k)Pre-morbid, ongoing depression or psychosis.

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00156676

Locations
United States, Rhode Island
Program to Integrate Psychosocial and Health Services in Chronic Diseases and Disability    
      Providence, Rhode Island, United States, 02908-4799

Sponsors and Collaborators

Investigators
Principal Investigator:     Albert Lo, MD     Program to Integrate Psychosocial and Health Services in Chronic Diseases and Disability    
  More Information

Responsible Party:   Department of Veterans Affairs ( Lo, Albert - Principal Investigator )
Study ID Numbers:   B4031I
First Received:   September 8, 2005
Last Updated:   June 3, 2008
ClinicalTrials.gov Identifier:   NCT00156676
Health Authority:   United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Disability  
Gait  
Multiple Sclerosis  
Rehabilitation  
Robot  

Study placed in the following topic categories:
Autoimmune Diseases
Multiple Sclerosis
Demyelinating Diseases
Demyelinating Autoimmune Diseases, CNS
Demyelinating diseases
Sclerosis
Autoimmune Diseases of the Nervous System

Additional relevant MeSH terms:
Pathologic Processes
Immune System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers